Like to Know More?
eMail or Call
Speak with a clinical consultant:
For Patient, Technical, and General Inquiries
The On-X valve’s hemodynamic performance is one of the very best among valve prostheses, particularly in smaller sizes. Table 1 compares the mean pressure gradients and maximum body surface area of the On-X valve size 19 with other competitors’ valves fitting a 19mm annulus.
Table 1. Hemodynamic Performance1-7
19 mm Annulus
|EOA* (cm2)||GOA** (cm2)||BSA*** (m)|
|CMI Supra-annular 21||16.2||1.3||1.46||1.53|
|Medtronic Advantage 19||16.0||1.0||not available||1.18|
|Medtronic Freestyle||12.0||1.1||not available||1.29|
|Edwards Perimount||22||0.82||not available||0.96|
*Effective Orifice Area
Intra-Annular Flared Walls Preserve – Hemodynamic Benefit
The On-X valve hemodynamics benefit extend beyond outstanding gradients. While many valves vacate the annulus to increase orifice area, the On-X valve extends through the annulus, protecting against ingrowth to preserve the full geometric orifice area of the valve over time.
The Thrill is Gone!
With On-X aortic valves, surgeons report an absence of a “thrill” within the aorta of implanted patients.
Following implantation of an aortic valve prosthesis and removal of the cross-clamp, many surgeons pause to palpate the patient’s aorta. This habit provides a tactile confirmation that the implanted valve is functioning properly. With bileaflet mechanical valves, surgeons report that they characteristically feel an unnatural “thrill” (vibration) in the aorta.
The absence of thrill with On-X valves is a further indication that efforts to reduce turbulence have met with success. On-X valves are designed to emulate the natural flow of the native valve with hemodynamic features like the inlet flare, thinner orifice walls, natural length and fully opening leaflets.
Best Overall Performance
The evolutionary new shape of the On-X valve is defined by sound fluid dynamic principles that reduce turbulence, pressure gradients and hemolysis. No other valve provides such comprehensive benefit to the patient’s well-being.
- On-X: On-X Prosthetic Heart Valve, Summary of Safety and Effectiveness Data submitted to the United States Food and Drug Administration. PMA P000037. Approveal date May 30, 2001 and October 11, 2002
- SJM Regent: SJM Regent Valve. Clinical Study Summary (package insert)
- ATS 16/19: ATS Open Pivot Bileaflet Heart Valve. Summary of Safety and Effectiveness Data submitted to the United States Food and Drug Administration. PMA P990046. Approval date October 13, 2000
- CMI: CarboMedics Prosthetic Heart Valve. Summary of Safety and Effectiveness Data submitted to the United States Food and Drug Administration. PMA P900060. Approval date April 13, 1993
- Medtronic Freestyle: Medtronic Freestyle Aortic Root Prosthesis. Summary of Safety and Effectiveness Data submitted to the United States Food and Drug Administration. PMA 970031 Approval date November 26, 1997
- Edwards Perimount: Edwards Life Sciences Carpentier-Edwards Perimount Magna Pericardial Bioprosthesis. Instructions for Use. Copyright 2003